Evaluation of Potential for Drug Interaction Between SCH 58235 (Ezetimibe) and Pitavastatin (Study P03962)(COMPLETED)
Status:
Completed
Trial end date:
2004-09-01
Target enrollment:
Participant gender:
Summary
This study was designed to evaluate the pharmacokinetic interaction and safety of
coadministration of SCH 58235 (ezetimibe) and pitavastatin in healthy Japanese adult male
subjects or adult male subjects having no obvious disease other than high cholesterol levels.